MISFOLDED TDP-43 BINDING MOLECULES

The present invention is in the field of transactive response DNA binding protein with a molecular weight of 43 kDa (TARDB or also TDP-43). The invention relates to TDP-43 specific binding molecules,in particular to anti-TDP-43 antibodies or an antigen-binding fragment or a derivative thereof and us...

Full description

Saved in:
Bibliographic Details
Main Authors SEREDENINA TAMARA, ADOLFSSON OSKAR
Format Patent
LanguageChinese
English
Published 03.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is in the field of transactive response DNA binding protein with a molecular weight of 43 kDa (TARDB or also TDP-43). The invention relates to TDP-43 specific binding molecules,in particular to anti-TDP-43 antibodies or an antigen-binding fragment or a derivative thereof and uses thereof. The present invention provides means and methods to diagnose, prevent, alleviate and/ortreat a disorder and/or abnormality associated with misfolded TDP-43 including but not limited to frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD, sporadicand familial), and/or Parkinson's disease (PD). The present invention provides modified conformation-specific antigenic peptides and peptide fragments derived from the TDP-43 protein and the antibodies obtainable by said peptides or fragments for use in the diagnosis, prevention, alleviation and/or treatment of TDP-43-related disorders and/or abnormalities. 本发明属于分子量为43kDa的反式激活应答DNA结合蛋白(TARDB或也称为TDP-43)的领域。本发明涉及TDP-43特异性结合分
Bibliography:Application Number: CN201980012546